Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1251-1256

  El Solh, Ali A ^a,b,c   Vora, Hardik ^b   Knight, Paul R ^a,c   Porhomayon, Jahan ^a,c  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

aspiration pneumonia; aspiration pneumonitis; intensive care unit; outcome; procalcitonin

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; MACROLIDE; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN; QUINOLONE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; APACHE; AREA UNDER THE CURVE; ARTICLE; ASPIRATION PNEUMONIA; ASSISTED VENTILATION; BACTERIAL ASPIRATION PNEUMONIA; BACTERIUM CULTURE; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENTEROBACTER; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FUSOBACTERIUM; GLASGOW COMA SCALE; HAEMOPHILUS INFLUENZAE; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PEPTOSTREPTOCOCCUS; PREDICTION; PREDICTIVE VALIDITY; PREVOTELLA; PRIORITY JOURNAL; PROCALCITONIN BLOOD LEVEL; PROSPECTIVE STUDY; PULMONARY ASPIRATION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEROLOGY; SERRATIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; TREATMENT DURATION;

EID: 79957636566     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31820a942c     Document Type: Article

References (31)

1. Assicot M, Bohuon C, Gendrel D, et al: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-518. (Pubitemid 23066085)
2. Gendrel D, Bohuon C: Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19:679-687.
3. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004; 363:600-607. (Pubitemid 38264177)
4. Simon P, Milbrandt E, Emlet L: Procalcitonin- guided antibiotics in severe sepsis. Crit Care 2008; 12:309.
5. Schuetz P, Christ-Crain M, Thomann R, et al: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The Pro- HOSP randomized controlled trial. JAMA 2009; 302:1059-1066.
6. Stolz D, Smyrnios N, Eggimann P, et al: Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: A randomized study. Eur Respir J 2009; 34: 1364-1375.
7. Hochreiter M, Kö hler T, Schweiger AM, et al: Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial. Crit Care 2009; 13:R83.
8. Nobre V, Harbarth S, Graf JD, et al: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial. Am J Respir Crit Care Med 2008; 177: 498-505. (Pubitemid 351442188)
9. Bouadma L, Luyt CE, Tubach F, et al: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomized controlled trial. Lancet 2010; 375:463-474.
10. Remskar M, Horvat M, Hojker S, et al: Procalcitonin in patients with acute myocardial infarction. Wien Klin Woschenschr 2002; 114:205-210. (Pubitemid 34298149)
11. Kallio R, Surcel HM, Bloigu A, et al: C-reactive protein, procalcitonin, and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000; 36:889-894. (Pubitemid 30214139)
12. Martinot M, Hansmann Y, De Martino S, et al: Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults. Press Med 2001; 30:1091-1096. (Pubitemid 32634666)
13. Meisner M: Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002; 323:17-29. (Pubitemid 34804792)
14. El-Solh AA, Akinnusi ME, Peter M, et al: Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. Intensive Care Med 2008; 34:1012-1019. (Pubitemid 351903801)
15. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-383. (Pubitemid 17055592)
16. Knaus WA, Draper EA, Wagner DP, et al: APACHE II a severity of disease classification system. Crit Care Med 1985; 13:818-829. (Pubitemid 15250137)
17. El-Solh AA, Aquilina AT, Dhillon RS, et al: Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med 2002; 166: 1038-1043. (Pubitemid 35178700)
18. Nylén ES, Snider RH, Thompson KA, et al: Pneumonitis-associated hyperprocalcitonemia. Am J Med Sci 1996; 312:12-18.
19. Pusch F, Wildling E, Freitag H, et al: Procalcitonin as a diagnostic marker in patients with aspiration after closed head injury. Wien Klin Wochenschr 2001; 113:676-680. (Pubitemid 32899960)
20. Luyt CE, Combes A, Reynaud C, et al: Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008; 34:1434-1440.
21. Gibot S, Cravoisy A, Levy B, et al: Soluble triggering receptor expressed on myeloid cell and the diagnosis of pneumonia. N Engl J Med 2004; 350:451-458. (Pubitemid 38133765)
22. Jung B, Embriaco N, Roux F, et al: Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score. Intensive Care Med 2010; 36: 790-798.
23. Schuetz P, Affolter B, Hunziker S, et al: Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: A retrospective cohort study. Eur J Clin Invest 2010; 40:376-381.
24. Meisner M: Procalcitonin: Experience with a new diagnostic tool for bacterial infection and systemic inflammation. J Lab Med 1999; 23:263-272. (Pubitemid 29255495)
25. Seligman R, Meisner M, Lisboa TC, et al: Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006; 10:R125.
26. Luyt CE, Guerin V, Combes A, et al: Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005; 171:48-53. (Pubitemid 40051694)
27. Christ-Crain M, Stolz D, Bingisser R, et al: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 2006; 174:3-5.
28. Briel M, Schuetz P, Mueller B, et al: Procalcitonin- guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008; 168:2000-2007.
29. Linssen CF, Bekers O, Drent M, et al: C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 2008; 45: 293-298. (Pubitemid 351724566)
30. Duflo F, Debon R, Monneret G, et al: Alveolar and serum procalcitonin: Diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 2002; 96:74-79. (Pubitemid 34032485)
31. Mylotte J, Goodnough S, Gould M: Pneumonia versus pneumonitis in nursing home residents: Prospective application of a clinical algorithm. J Am Geriatr Soc 2005; 53: 755-761 (Pubitemid 41656919)